financetom
Business
financetom
/
Business
/
Full Circle Lithium Sales of Lithium-ion Battery Firefighting Agent Pass US$300,000
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Full Circle Lithium Sales of Lithium-ion Battery Firefighting Agent Pass US$300,000
Nov 11, 2024 5:52 AM

08:28 AM EST, 11/11/2024 (MT Newswires) -- Full Circle Lithium ( FCLIF ) , a U.S.-based lithium-products manufacturer, on Monday said that sales of FCL-X, the company's lithium-ion battery fire-extinguishing agent, has surpassed US$300,000.

"We are very pleased to see that we achieved meaningful non-recurring sales of FCL-X in all product lines in the past few weeks even though we have just begun our marketing and sales efforts, including signing up with US specialty fire safety distributor AEST Fire & Safety," said CEO Carlos Vicens.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Coeptis Therapeutics Receives Nasdaq Listing Extension
Coeptis Therapeutics Receives Nasdaq Listing Extension
Sep 22, 2024
08:48 AM EDT, 09/19/2024 (MT Newswires) -- Coeptis Therapeutics ( COEP ) said Thursday that it received approval from the Nasdaq Hearings Panel to remain listed on Nasdaq through Jan. 15, 2025. The company was granted a Nasdaq listing extension after presenting a plan, including a reverse stock split, to address the minimum bid price requirement. Nasdaq issued a notice...
Aethlon Medical Receives Ethics Approval for Hemopurifier Cancer Trial in India
Aethlon Medical Receives Ethics Approval for Hemopurifier Cancer Trial in India
Sep 22, 2024
08:49 AM EDT, 09/19/2024 (MT Newswires) -- Aethlon Medical ( AEMD ) said Thursday that the Medanta Institutional Ethics Committee has granted full ethics approval for its clinical trial of the Hemopurifier in cancer patients undergoing anti-PD-1 therapy. The approval is valid for one year, followed by annual reviews. The trial, which received a no objection certificate from Indian regulators,...
Arqit Quantum to Implement 1-for-25 Reverse Share Split
Arqit Quantum to Implement 1-for-25 Reverse Share Split
Sep 22, 2024
08:47 AM EDT, 09/19/2024 (MT Newswires) -- Arqit Quantum ( ARQQ ) said Thursday its board approved a 1-for-25 reverse share split. The company's stock will begin trading on a split-adjusted basis on Nasdaq from Sept. 25, Arqit Quantum ( ARQQ ) said. The provider of cybersecurity services said it expects to regain compliance with Nasdaq's minimum bid price requirement...
Cadiz Appoints Cathryn Rivera as Chief Operating Officer
Cadiz Appoints Cathryn Rivera as Chief Operating Officer
Sep 22, 2024
09:03 AM EDT, 09/19/2024 (MT Newswires) -- Cadiz (CDZI) said Thursday it appointed Cathryn Rivera as chief operating officer, effective Sept. 16. Before joining the company, Rivera served as appointments secretary for California Governor Gavin Newsom from 2019 to 2024, Cadiz said. Price: 3.2500, Change: +0.04, Percent Change: +1.25 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved